New growth hormone injection aims to help short children grow taller
NCT ID NCT07450053
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new drug called GenSci134, a growth hormone injection, in 128 children with idiopathic short stature (short height with no known cause). The trial has two parts: first, a single-dose phase to check safety and how the body processes the drug; second, a multiple-dose phase comparing GenSci134 to an existing growth hormone (Norditropin) to see if it improves growth rate over 24 weeks. The goal is to find the right dose and confirm it is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GenSci134 (a new growth hormone injection)
What this could lead to
If successful, this could offer a new treatment option to help children with idiopathic short stature grow taller.
What could go wrong
This is an early-phase trial with only 128 participants, so results may not apply to all children. The new drug may not work better than existing growth hormone or could have unexpected side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC SHORT STATURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
Wuhan, Hubei, 430000, China